NASDAQ: GNMK       Genmark Diagnostics
Last Price Today's Change   Day's Range   Trading Volume
19.80   +0.75 (3.94%)  18.914 - 20.11  261,537


Avg Volume (4 weeks):1,514,378
4 Weeks Range:13.60 - 23.59
4 Weeks Price Volatility (%):
52 Weeks Range:3.37 - 23.59
52 Weeks Price Volatility (%):
Average Price Target: 14.00
Price Target Upside/Downside: -5.80


No recent Headlines for this stock.

Business Background

GenMark Diagnostics Inc is a molecular diagnostics company. Its key offerings are instruments and diagnostic tests based on eSensor electrochemical technology, which can detect multiple biomarkers in a single patient sample. GenMark’s XT-8 system is sold to hospitals and reference laboratories and has a menu of several diagnostic tests, which include panels for respiratory viruses, cystic fibrosis genotyping, warfarin sensitivity, and thrombophilia risk. This workstation can run up to 24 independent test cartridges at a time and produces results in roughly 30 minutes. The majority of GenMark’s sales occur within the United States.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2139  4310  289  3283 

Top 10 Active Counters
 SNDL 1.405+0.055 
 WPX 9.43+0.48 
 SOS 7.20+0.51 
 NIO 44.91-4.85 
 SNSS 5.32+1.04 
 RKT 29.38+5.08 
 AAPL 125.76-2.03 
 AMC 8.868-0.312 
 PE 16.93+0.52 
 CFMS 1.205+0.145